Pneumonia (main): Difference between revisions
No edit summary |
No edit summary |
||
| Line 21: | Line 21: | ||
# Sputum staining | # Sputum staining | ||
## If concern for particular organism | ## If concern for particular organism | ||
==Health care–associated PNA risk factors== | |||
#Pts hospitalized for 2 or more days w/in past 90d | |||
#Nursing home/long-term care residents | |||
#Pts receiving home IV abx | |||
#Dialysis pts | |||
#Pts receiving chronic wound care | |||
#Pts receiving chemotherapy | |||
#Immunocompromised pts | |||
==Pseudomonas risk factors== | |||
# Alcoholism | |||
# Immunosuppression (incl. steroids) | |||
# Structural lung disease | |||
# Malnutrition | |||
# Recent abx | |||
# Recent hospital stay | |||
==Treatment== | ==Treatment== | ||
===Outpatient, community-acquired PNA=== | |||
====Healthy==== | |||
===Outpatient=== | #Clarithromycin XL 1000mg PO QD x7d OR | ||
#Azithromycin 500mg PO day 1, 250mg on days 2-5 OR | |||
#Doxycycline 100mg BID x 10-14d (2nd line choice) | |||
====Unhealthy==== | |||
#Chronic heart, lung, liver, or renal disease; DM, alcholism, malignancy | |||
# | |||
##Levofloxacin 750mg QD x5d OR | ##Levofloxacin 750mg QD x5d OR | ||
##Moxifloxacin 400mg QD x7-14d OR | ##Moxifloxacin 400mg QD x7-14d OR | ||
| Line 36: | Line 52: | ||
##3rd generation cephalosporin AND azithromycin | ##3rd generation cephalosporin AND azithromycin | ||
===Inpatient=== | ===Inpatient=== | ||
====Community-acquired PNA==== | |||
#Levofloxacin 750mg QD x5d OR | |||
#Moxifloxacin 400mg QD x7-14d OR | |||
#3rd generation cephalosporin AND azithromycin | |||
#ICU, low risk of pseudomonas | ====Health Care-associated PNA==== | ||
## | #3-drug regimen recommended | ||
#ICU, risk of pseudomonas | ##(Cefepime 1-2gm q8-12h OR ceftazidime 2gm q8h) + cipro 400mg q8h + vanco 15mg/kg q12 OR | ||
##Imipenem 500mg q6hr + cipro 400mg q8hr + vanco 15mg/kg q12 OR | |||
##Piperacillin-tazobactam 4.5gm q6h + cipro 400mg q8h + vanco 15mg/kg q12 | |||
====ICU, low risk of pseudomonas==== | |||
#Ceftriaxone 1gm IV and Azithromycin 500mg IV OR | |||
#Ceftriaxone 1gm IV and (moxifloxacin 400mg IV or levofloxacin 750mg IV) | |||
#Penicillin allergy | |||
##Moxi/levofloxacin and (aztreonam 1-2gm IV or clindamycin 600mg IV) | |||
====ICU, risk of pseudomonas==== | |||
## Cefipime, imipenem, OR piperacillin-tazobactam + IV cipro/levo | ## Cefipime, imipenem, OR piperacillin-tazobactam + IV cipro/levo | ||
## Cefipime, imipenem, OR piperacillin-tazobactam + gent + azithromycin | ## Cefipime, imipenem, OR piperacillin-tazobactam + gent + azithromycin | ||
## Cefipime, imipenem, OR piperacillin-tazobactam + gent + cipro/levo | ## Cefipime, imipenem, OR piperacillin-tazobactam + gent + cipro/levo | ||
==Disposition== | ==Disposition== | ||
Revision as of 22:55, 23 July 2011
Background
3 questions:
- Does this pt have pneumonia?
- If yes, does this pt need to be admitted?
- If yes, admit to the ward or ICU?
Clinical Presentation
- Fever, chills, pleuritic CP, productive cough
- Fever is seen in 80%
- Tachypnea
- Most sensitive sign in elderly
- Abdominal pain, N/V/diarrhea may be seen with Legionella infection
Work-Up
- CXR
- CBC
- Chemistry
If pt will be admitted:
- Blood cx (required if pt may require ICU during their course)
- Sputum staining
- If concern for particular organism
Health care–associated PNA risk factors
- Pts hospitalized for 2 or more days w/in past 90d
- Nursing home/long-term care residents
- Pts receiving home IV abx
- Dialysis pts
- Pts receiving chronic wound care
- Pts receiving chemotherapy
- Immunocompromised pts
Pseudomonas risk factors
- Alcoholism
- Immunosuppression (incl. steroids)
- Structural lung disease
- Malnutrition
- Recent abx
- Recent hospital stay
Treatment
Outpatient, community-acquired PNA
Healthy
- Clarithromycin XL 1000mg PO QD x7d OR
- Azithromycin 500mg PO day 1, 250mg on days 2-5 OR
- Doxycycline 100mg BID x 10-14d (2nd line choice)
Unhealthy
- Chronic heart, lung, liver, or renal disease; DM, alcholism, malignancy
- Levofloxacin 750mg QD x5d OR
- Moxifloxacin 400mg QD x7-14d OR
- Amoxicillin-clavulanate 2g BID AND Azithromycin 500mg day 1, 250mg days 2-5 OR
- 3rd generation cephalosporin AND azithromycin
Inpatient
Community-acquired PNA
- Levofloxacin 750mg QD x5d OR
- Moxifloxacin 400mg QD x7-14d OR
- 3rd generation cephalosporin AND azithromycin
Health Care-associated PNA
- 3-drug regimen recommended
- (Cefepime 1-2gm q8-12h OR ceftazidime 2gm q8h) + cipro 400mg q8h + vanco 15mg/kg q12 OR
- Imipenem 500mg q6hr + cipro 400mg q8hr + vanco 15mg/kg q12 OR
- Piperacillin-tazobactam 4.5gm q6h + cipro 400mg q8h + vanco 15mg/kg q12
ICU, low risk of pseudomonas
- Ceftriaxone 1gm IV and Azithromycin 500mg IV OR
- Ceftriaxone 1gm IV and (moxifloxacin 400mg IV or levofloxacin 750mg IV)
- Penicillin allergy
- Moxi/levofloxacin and (aztreonam 1-2gm IV or clindamycin 600mg IV)
ICU, risk of pseudomonas
- Cefipime, imipenem, OR piperacillin-tazobactam + IV cipro/levo
- Cefipime, imipenem, OR piperacillin-tazobactam + gent + azithromycin
- Cefipime, imipenem, OR piperacillin-tazobactam + gent + cipro/levo
Disposition
See Also
Source
UpToDate
